AMERICAN FROZEN FOOD INSTITUTE v. MATHEWS Case Brief
Complete case briefs with LSD+
Every LSD.Law brief pairs a full IRAC analysis with opinion summaries at three levels of depth, written by a team of Harvard Law and MIT graduates - a quick synopsis when you are pressed for time, the complete reasoning when you need to go deep.
Adaptive Case Views
Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.
Exam-Ready IRAC Format
We deliver the precise structure professors look for in exam answers.
Complex Cases, Clarified
We break down dense legal reasoning into something digestible, helping you grasp core concepts.
Case Brief Summary & Legal Analysis
tl;dr: A food industry group challenged the FDA’s authority to create “common and usual names” for foods via general rulemaking. The court upheld the FDA’s regulations, affirming an agency’s broad power to issue substantive rules to efficiently enforce its governing statute.
Legal Significance: This case affirms an agency’s broad authority to use informal, substantive rulemaking under a general statutory grant of power (§ 701(a)) to enforce specific statutory provisions, rather than being limited to formal rulemaking or case-by-case adjudication.
AMERICAN FROZEN FOOD INSTITUTE v. MATHEWS Law School Study Guide
Use this case brief structure for your own legal analysis. Focus on the IRAC methodology to excel in law school exams and cold calls.
Case Facts & Court Holding
Key Facts & Case Background
The Food and Drug Administration (FDA), acting under its general rulemaking authority in § 701(a) of the Federal Food, Drug, and Cosmetic Act (FDCA), promulgated regulations establishing “common or usual names” for nonstandardized foods to provide consumers with more informative labeling. The American Frozen Food Institute (AFFI) challenged two specific regulations: one for “frozen heat and serve dinners” and one for “seafood cocktails.” AFFI argued that the FDA lacked the statutory authority to create common and usual names through general, informal rulemaking. It contended the FDA could only recognize existing names through formal, on-the-record proceedings under § 701(e) (used for establishing “standards of identity”) or through case-by-case enforcement actions. AFFI specifically claimed the “dinner” regulation was a de facto standard of identity because it required listing certain food components, and the “seafood cocktail” regulation unlawfully mandated percentage-of-ingredient labeling, a power it argued Congress had withheld. The FDA maintained its actions were a valid exercise of its authority to efficiently enforce the FDCA’s misbranding provisions.
Court Holding & Legal Precedent
Issue: Does the Food and Drug Administration possess the authority under its general rulemaking power to promulgate substantive regulations establishing “common or usual names” for nonstandardized foods, including requirements for component listing and percentage-of-ingredient labeling?
Yes. The court held that the FDA acted within its statutory authority. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem i
IRAC Legal Analysis
About IRAC analysis
IRAC (Issue, Rule, Analysis, Conclusion) is the structure professors expect in exam answers. Each LSD.Law brief states the issue, the governing rule with citations, the court's application of that rule, and the conclusion - the same reasoning pattern you will use on exams and in practice.
Legal Issue
Does the Food and Drug Administration possess the authority under its general rulemaking power to promulgate substantive regulations establishing “common or usual names” for nonstandardized foods, including requirements for component listing and percentage-of-ingredient labeling?
Conclusion
This case serves as a key precedent supporting an agency's expansive power Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
Legal Rule
An administrative agency's general grant of rulemaking authority, such as the power Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint oc
Legal Analysis
The court's analysis centered on the scope of the FDA's rulemaking authority Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
Flash-to-Full Case Opinions
Flash Summary
- The FDA has authority under its general rulemaking power (§ 701(a)